Challenges and opportunities for siRNA-based cancer treatment

Area of Science:

• Oncology
• Molecular Biology
• Biotechnology

Background:

• Cancer involves complex genetic and epigenetic disorders, making it a prime target for novel therapies.
• Small interfering RNA (siRNA) therapy is a key focus in oncology, with many clinical trials underway.
• Despite academic interest, siRNA cancer treatments face clinical development challenges.

Purpose of the Study:

• To review key challenges in clinical siRNA-based cancer treatment.
• To explore opportunities for translating siRNA technology to oncologic clinics.

Main Methods:

• Analysis of recent clinical and preclinical studies on siRNA cancer therapy.
• Identification of critical obstacles in siRNA development.

Main Results:

• Key challenges include chemical modification, tumor penetration, endosomal escape, target selection, and off-target effects.
• Recent studies highlight specific difficulties in translating siRNA technology.

Conclusions:

• Overcoming identified challenges is crucial for successful clinical translation of siRNA cancer therapy.
• Further research and strategic development are needed to realize the potential of siRNA in oncology.